Toll Free: 1-888-928-9744

Hidradenitis Suppurativa Global Clinical Trials Review, H1, 2016

Published: Mar 31, 2016 | Pages: 47 | Publisher: GlobalData | Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

Hidradenitis Suppurativa Global Clinical Trials Review, H1, 2016

Summary

GlobalData's clinical trial report, "Hidradenitis Suppurativa Global Clinical Trials Review, H1, 2016" provides an overview of Hidradenitis Suppurativa clinical trials scenario. This report provides top line data relating to the clinical trials on Hidradenitis Suppurativa. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to Buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
 Table of Contents
Table of Contents 2 List of Tables 3 List of Figures 3 Report Guidance 4 Clinical Trials by Region 5 Clinical Trials and Average Enrollment by Country 6 Top Countries Contributing to Clinical Trials in Asia-Pacific 9 Top Five Countries Contributing to Clinical Trials in Europe 10 Top Countries Contributing to Clinical Trials in North America 11 Clinical Trials by G7 Countries: Proportion of Hidradenitis Suppurativa to Dermatology Clinical Trials 12 Clinical Trials by Phase in G7 Countries 13 Clinical Trials in G7 Countries by Trial Status 14 Clinical Trials by E7 Countries: Proportion of Hidradenitis Suppurativa to Dermatology Clinical Trials 15 Clinical Trials in E7 Countries by Trial Status 16 Clinical Trials by Phase 17 In Progress Trials by Phase 18 Clinical Trials by Trial Status 19 Clinical Trials by End Point Status 20 Subjects Recruited Over a Period of Time 21 Clinical Trials by Sponsor Type 22 Prominent Sponsors 23 Top Companies Participating in Hidradenitis Suppurativa Therapeutics Clinical Trials 24 Prominent Drugs 26 Clinical Trial Profile Snapshots 27 Appendix 44 Abbreviations 44 Definitions 44 Research Methodology 45 Secondary Research 45 About GlobalData 46 Contact Us 46 Disclaimer 46 Source 47
List of Tables
Hidradenitis Suppurativa Therapeutics, Global, Clinical Trials by Region, 2016* 5 Hidradenitis Suppurativa Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7 Hidradenitis Suppurativa Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8 Hidradenitis Suppurativa Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2016* 9 Hidradenitis Suppurativa Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 10 Hidradenitis Suppurativa Therapeutics Clinical Trials, North America, Top Countries, 2016* 11 Proportion of Hidradenitis Suppurativa to Dermatology Clinical Trials, G7 Countries (%), 2016* 12 Hidradenitis Suppurativa Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 13 Hidradenitis Suppurativa Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 14 Proportion of Hidradenitis Suppurativa to Dermatology Clinical Trials, E7 Countries (%), 2016* 15 Hidradenitis Suppurativa Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 16 Hidradenitis Suppurativa Therapeutics, Global, Clinical Trials by Phase, 2016* 17 Hidradenitis Suppurativa Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 18 Hidradenitis Suppurativa Therapeutics, Global, Clinical Trials by Trial Status, 2016* 19 Hidradenitis Suppurativa Therapeutics Clinical Trials, Global, by End Point Status, 2016* 20 Hidradenitis Suppurativa Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 21 Hidradenitis Suppurativa Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 22 Hidradenitis Suppurativa Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 23 Hidradenitis Suppurativa Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 25 Hidradenitis Suppurativa Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 26


List of Figures
Hidradenitis Suppurativa Therapeutics, Global, Clinical Trials by Region (%), 2016* 5 Hidradenitis Suppurativa Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 6 Hidradenitis Suppurativa Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8 Hidradenitis Suppurativa Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 10 Hidradenitis Suppurativa Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 11 Proportion of Hidradenitis Suppurativa to Dermatology Clinical Trials, G7 Countries (%), 2016* 12 Hidradenitis Suppurativa Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 13 Hidradenitis Suppurativa Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 14 Proportion of Hidradenitis Suppurativa to Dermatology Clinical Trials, E7 Countries (%), 2016* 15 Hidradenitis Suppurativa Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 16 Hidradenitis Suppurativa Therapeutics, Global, Clinical Trials by Phase (%), 2016* 17 Hidradenitis Suppurativa Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 18 Hidradenitis Suppurativa Therapeutics, Global, Clinical Trials by Trial Status, 2016* 19 Hidradenitis Suppurativa Therapeutics Clinical Trials, Global, by End Point Status, 2016* 20 Hidradenitis Suppurativa Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 21 Hidradenitis Suppurativa Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 22 Hidradenitis Suppurativa Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 23 Hidradenitis Suppurativa Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 24 Hidradenitis Suppurativa Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 26 GlobalData Methodology 45

To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global non halogenated flame retardants market size is anticipated to be valued at USD 2.54 billion by 2020, as per a new research report by Radiant Insights, Inc. Increasing safety materials demand owing to low heat & smoke emission properties in c

Read More...

Global air traffic control equipment market is projected to reach USD 4.2 billion by 2020, as per a new research report by Radiant Insights, Inc. Mounting price sensitivity among customers with introduction of low fare airlines is expected to drive t

Read More...

U.S hairbrush market is estimated to exceed USD 1.2 billion by 2022, as per a new research report by Radiant Insights, Inc. Rising population along with ascending disposable income is expected to drive industry demand. Significant rise in disposable

Read More...

Global aquafeed market size is anticipated to be valued at USD 165.04 billion by 2022, as per a new research report by Radiant Insights, Inc. Increase in fish consumption for direct and indirect consumer applications is anticipated to drive the marke

Read More...

Global agricultural films market size is anticipated to reach USD 10.5 billion by 2020, as per a new research report by Radiant Insights, Inc. Increasing need to raise agricultural productivity, in order to meet surplus demand by growing population i

Read More...
Choose License Type
Single User - US $2500
Multi User - US $5000
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify